2nd Circ. Mulls Legality Of MD's 'Icky' Drug Stock Trades
The Second Circuit asked Wednesday whether a clinical trial doctor's "icky" decision to trade on confidential information about a drug company he worked for violated insider-trading law in the absence of...To view the full article, register now.
Already a subscriber? Click here to view full article